Literature DB >> 3226610

Intracerebroventricular injection of brain natriuretic peptide inhibits vasopressin secretion in conscious rats.

T Yamada1, K Nakao, H Itoh, G Shirakami, K Kangawa, N Minamino, H Matsuo, H Imura.   

Abstract

The effect of intracerebroventricular (i.c.v.) injection of brain natriuretic peptide (BNP), a novel peptide purified from the porcine brain, on arginine vasopressin (AVP) secretion was studied in conscious, unrestrained rats and was compared with that of atrial natriuretic polypeptide (ANP). I.c.v. administration of BNP (0.01, 0.1 or 1 nmol) significantly inhibited basal AVP secretion and the effect of BNP was comparable to that of ANP. The AVP secretion induced by i.c.v. injection of angiotensin II (0.1 nmol) was significantly suppressed by the pretreatment with BNP (0.1 or 1 nmol). These results suggest that BNP is involved in the central control of AVP secretion either alone or in combination with brain ANP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3226610     DOI: 10.1016/0304-3940(88)90661-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Water intake, thirst, and copeptin responses to two dehydrating stimuli in lean men and men with obesity.

Authors:  Douglas C Chang; Adela Penesova; Joy C Bunt; Emma J Stinson; Stavros A Kavouras; Marci E Gluck; Ethan Paddock; Mary Walter; Paolo Piaggi; Jonathan Krakoff
Journal:  Obesity (Silver Spring)       Date:  2022-08-02       Impact factor: 9.298

2.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

3.  Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; H Tanaka; K Kikuta; H Sumida; H Kato; M Jougasaki; K Nakao
Journal:  Br Heart J       Date:  1994-12

Review 4.  Natriuretic hormones in brain function.

Authors:  Anastasia Hodes; David Lichtstein
Journal:  Front Endocrinol (Lausanne)       Date:  2014-11-28       Impact factor: 5.555

5.  Investigation of changes in brain natriuretic peptide serum levels and its diagnostic value in patients with mild and moderate head trauma, in patients referred to emergency department of Alzahra Hospital, Isfahan, 2013-2014.

Authors:  Reza Azizkhani; Es'haq Keshavarz
Journal:  Adv Biomed Res       Date:  2016-12-27

Review 6.  Epigenetic Programming of Synthesis, Release, and/or Receptor Expression of Common Mediators Participating in the Risk/Resilience for Comorbid Stress-Related Disorders and Coronary Artery Disease.

Authors:  Carlos Manuel Zapata-Martín Del Campo; Martín Martínez-Rosas; Verónica Guarner-Lans
Journal:  Int J Mol Sci       Date:  2018-04-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.